Código QR (código de barras bidimensional)

Recent Advances in Nanoparticles-Based Platforms Targeting the PD-1/PD-L1 Pathway for Cancer Treatment

Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis showed remarkable improvements in overall response and patient survival, which changed the treatment landscape for multiple cancer types. However, the majority of patients receiving ICIs are either non-responders or eventually develop...

ver descrição completa

Na minha lista:
Principais autores: Xin Yu, Chao Fang, Kun Zhang, Chunxia Su
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-07-01
coleção:Pharmaceutics
Assuntos:
PD-1/PD-L1
immune checkpoint
nanoparticles
delivery nanoplatforms
cancer immunotherapy
Acesso em linha:https://www.mdpi.com/1999-4923/14/8/1581
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados